|
Volumn 110, Issue 7, 2007, Pages 2777-2778
|
Antithrombin cambridge II (A384S): Prevalence in patients of the Paris Thrombosis Study (PATHROS) [11]
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTITHROMBIN;
GENOMIC DNA;
PRIMER DNA;
ALLELE;
ANTITHROMBIN DEFICIENCY;
CARDIOVASCULAR RISK;
CASE CONTROL STUDY;
CONFIDENCE INTERVAL;
CONTROLLED STUDY;
EXON;
FRANCE;
GENE AMPLIFICATION;
GENE MUTATION;
GENETIC RISK;
GENOTYPE;
GEOGRAPHIC DISTRIBUTION;
HAPLOTYPE;
HUMAN;
LETTER;
LUNG EMBOLISM;
MAJOR CLINICAL STUDY;
MEASUREMENT;
MUTATIONAL ANALYSIS;
POLYMERASE CHAIN REACTION;
POPULATION RESEARCH;
PREVALENCE;
PRIORITY JOURNAL;
RISK FACTOR;
SCREENING;
SPAIN;
THROMBOPHILIA;
UNITED KINGDOM;
VEIN THROMBOSIS;
VENOUS THROMBOEMBOLISM;
WILD TYPE;
ALANINE;
ANTITHROMBIN III;
CASE-CONTROL STUDIES;
HUMANS;
MUTATION;
PARIS;
SERINE;
THROMBOSIS;
|
EID: 34948873156
PISSN: 00064971
EISSN: 00064971
Source Type: Journal
DOI: 10.1182/blood-2007-05-091835 Document Type: Letter |
Times cited : (7)
|
References (5)
|